Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04532619 · ClinicalTrials.gov registry record · NA
A Substance Use Adaptation of Fathering Through Change
A NA study of Substance Use and Parenting, sponsored by University of Oregon.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT04532619: Completed NA study of Substance Use and Parenting, sponsored by University of Oregon.
NCT04532619 is a NA study of Substance Use and Parenting that has completed, run by University of Oregon. The registered enrollment target is 41 participants, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04532619, a NA study of Substance Use and Parenting, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized control trial of the Fathering Through Change intervention, delivered via text messaging, to fathers in recovery for substance use disorders.
Primary Outcome
The Tool to Measure Parenting Self-Efficacy (TOPSE) consists of 48 self-efficacy statements. There are six self-efficacy statements for each domain and parents indicate how much they agree with each statement by responding to a Likert scale from 0-10 where 0 equates to completely disagree and 10 equates to completely agree. We administered the play, acceptance, and control domains. The overall score (0-10) was computed as the mean of these three sub-scale means. A higher overall score indicates
Conditions Studied
Interventions
- BEHAVIORAL Fathering Through Change
Study Locations (1)
Oregon
- Willamette Family Treatment Center - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT04532619 record still lists
NCT04532619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Fathering Through Change is the first listed.
NCT04532619 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04532619 about?
NCT04532619 is a clinical study titled "A Substance Use Adaptation of Fathering Through Change". This study is a randomized control trial of the Fathering Through Change intervention, delivered via text messaging, to fathers in recovery for substance use disorders.
What is the current status of trial NCT04532619?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2020-07-01. Estimated completion is 2021-12-31.
What conditions does trial NCT04532619 study?
This clinical trial studies the following conditions: Substance Use, Parenting.
What interventions are being tested in trial NCT04532619?
The interventions under investigation include: Fathering Through Change (BEHAVIORAL).
Who is sponsoring clinical trial NCT04532619?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04532619 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04532619's enrollment target sits among peer trials
41 80th of 88 higher than 9 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI